13F Portfolios

Alpha Wave Global, LP: ALTO NEUROSCIENCE INC (ANRO): Quarterly 13F Position History

As of Q1 2026, Alpha Wave Global, LP reported 3,707,757 shares of ALTO NEUROSCIENCE INC (ANRO), worth $83.4M and representing 10.5% of its 13F equity book. The position first appeared in Q1 2024 and has been disclosed across 9 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 9 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 3,707,757 0 $83.4M 10.5% $22.5
Q4 2025 3,707,757 0 $66.0M 8.1% $17.8
Q3 2025 3,707,757 0 $14.9M 1.5% $4.0
Q2 2025 3,707,757 0 $8.2M 0.9% $2.2
Q1 2025 3,707,757 0 $8.0M 3.6% $2.2
Q4 2024 3,707,757 0 $15.7M 7.3% $4.2
Q3 2024 3,707,757 0 $42.4M 13.2% $11.4
Q2 2024 3,707,757 +3,107,757 +518.0% $39.6M 13.3% $10.7
Q1 2024 600,000 $9.2M 3.3% $15.3

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Alpha Wave Global, LP first disclose a ANRO position in 13F-HR filings?

Alpha Wave Global, LP first reported ALTO NEUROSCIENCE INC (ANRO) on its 13F-HR filing for the period ending 2024-03-31 (Q1 2024). The position has appeared on 9 reported quarters within Pactolio's tracked window.

What was Alpha Wave Global, LP's most recent quarter-over-quarter share-count change in ANRO?

Alpha Wave Global, LP held the same 3,707,757 shares of ANRO between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.

Does the implied price-per-share represent Alpha Wave Global, LP's cost basis in ANRO?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.